References

AL-Masoudi, K.K., J.M. AL-Saffar and N.J. Kendla, 2015. Molecular characteristics of multidrug resistant Acinetobacter baumannii Isolated from Baghdad Hospitals. Iraqi J. Sci., 56: 1394-1399.
Direct Link  |  

Al-Ajeeli, S.S.M., 2014. Molculardetection of genomic islands responsible for Antimicrobial resistance in Acinetobacter baumannii Strain A92. Ph.D Thesis, University of Baghdad, Baghdad, Iraq.

Al-Bajlany, S.M.M., 2015. Detection of extended spectrum beta-lactam resistance genes in Acinetobacter baumannii isolated from clinical sources. MSc Thesis, University of Diayla, Baqubah, Iraq.

Al-Muhanna, A.S.J., 2006. A molcular and genetic study of virulence factors of Acinetobacter isolated from different infections. Ph.D Thesis, Al-Mustansiriya University, Baghdad, Iraq.

Aly, M.M., N.A. Alsoud, M.S. Elrobh, S.M. Al Johani and H.H. Balkhy, 2016. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur. J. Clin. Microbiol. Infect. Dis., 35: 1759-1766.
CrossRef  |  PubMed  |  Direct Link  |  

Anonymous, 2013. Acinetobacter in healthcare settings. Centers for Disease Control and Prevention, USA.

Antunes, L.C.S., P. Visca and K.J. Towner, 2014. Acinetobacter baumannii: Evolution of a global pathogen. Pathogens Dis., 71: 292-301.
CrossRef  |  Direct Link  |  

Bauernfeind, A., I. Stemplinger, R. Jungwirth, P. Mangold and S. Amann et al., 1996. Characterization of beta-lactamase gene blaPER-2 which encodes an extended-spectrum class a beta-lactamase. Antimicrob. Agents Chemother., 40: 616-620.
CrossRef  |  PubMed  |  Direct Link  |  

CLSI., 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A9, Clinical and Laboratory Standards Institute, Wayne, PA., USA.

Cao, J.R., X. Wei, Z.Q. Yan, D.X. Shen and Y.P. Luo, 2009. Study on the molecular characteristics of multidrug-resistant Acinetobacter baumannii. Zhonghua Liuxingbingxue Zazhi, 30: 832-835.
PubMed  |  Direct Link  |  

De Champs, C., L. Poirel, R. Bonnet, D. Sirot and C. Chanal et al., 2002. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob. Agents Chemother., 46: 3031-3034.
CrossRef  |  PubMed  |  Direct Link  |  

Dijkshoorn, L., A. Nemec and H. Seifert, 2007. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol., 5: 939-951.
CrossRef  |  Direct Link  |  

El Salabi, A., T.R. Walsh and C. Chouchani, 2013. Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria. Crit. Rev. Microbial., 39: 113-122.
CrossRef  |  PubMed  |  Direct Link  |  

Kim, J.W., S.T. Heo, J.S. Jin, C.H. Choi and Y.C. Lee et al., 2008. Characterization of Acinetobacter baumannii carrying bla_OXA.23bla_PER-1 and armA in a Korean Hospital. Clin. Microbial. Infect., 14: 716-718.
CrossRef  |  PubMed  |  Direct Link  |  

Kwon, N.Y., J.D. Kim and H.J. Pai, 2002. The resistance mechanisms of b-lactam Antimicrobials in clinical isolates of Acinetobacter baumannii. Korean J. Internal Med., 17: 94-99.
CrossRef  |  PubMed  |  Direct Link  |  

MacFaddin, J.F., 2000. Biochemical Tests for Identification of Medical Bacteria. 3rd Edn., Lippincott Williams & Wilkins, Pennsylvania, United States, ISBN: 0-683-05318-3, Pages: 912.

McConnell, M.J., L. Actis and J. Pachon, 2013. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev., 37: 130-155.
CrossRef  |  

Neuhauser, M.M., R.A. Weinstein, R. Rydman, L.H. Danziger and G. Karam et al., 2003. Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use. Jama, 289: 885-888.
CrossRef  |  PubMed  |  Direct Link  |  

Nordmann, P., S. Mariotte, T. Naas, R. Labia and M.H. Nicolas, 1993. Biochemical properties of a carbapenem hydrolyzing β lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother., 37: 939-946.
Direct Link  |  

Pereira, M., M. Perilli, E. Mantengoli, F. Luzzaro and A. Toniolo et al., 2000. PER-1 extended-spectrum β-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum Cephalosporins and monobactams from a hospital in Northern Italy. Microb. Drug Resist., 6: 85-90.
CrossRef  |  PubMed  |  Direct Link  |  

Perez, F., A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather and R.A. Bonomo, 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 51: 3471-3484.
CrossRef  |  PubMed  |  

Sacha, P., P. Wieczorek, D. Ojdana, S. Czaban and W Kłosowska et al., 2012. Susceptibility, phenotypes of resistance and extended-spectrum β-lactamases in Acinetobacter baumannii strains. Folia Histochemica Cytobiologica, 50: 46-51.
CrossRef  |  Direct Link  |  

Safari, M., M. Saidijam, A. Bahador, R. Jafari and M.Y. Alikhani, 2013. High prevalence of multidrug resistance and Metallo-beta-Lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J. Res. Health Sci., 13: 162-165.
PubMed  |  Direct Link  |  

Sengstock, D.M., R. Thyagarajan, J. Apalara, A. Mira and T. Chopra et al., 2010. Multidrug-resistant Acinetobacter baumannii: An emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis., 50: 1611-1616.
CrossRef  |  PubMed  |  Direct Link  |  

Siroy, A., V. Molle, C. Lemaitre-Guillier, D. Vallenet and M. Pestel-Caron et al., 2005. Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. Antimicrob. Agents Chemother., 49: 4876-4883.
CrossRef  |  PubMed  |  Direct Link  |  

Su, C.H., J.T. Wang, C.A. Hsiung, L.J. Chien and C.L. Chi et al., 2012. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: Association with hospital antimicrobial usage. PloS One, 7: 1-6.
CrossRef  |  PubMed  |  Direct Link  |  

Vahaboglu, H., F. Coskunkan, O. Tansel, R. Ozturk and N. Sahin et al., 2001. Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J. Med. Microbial., 50: 642-645.
CrossRef  |  PubMed  |  Direct Link  |  

Vahaboglu, H., R. Ozturk, G. Aygun, F. Coskunkan and A. Yaman et al., 1997. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicenter study. Antimicrobiol. Agents Chemother., 41: 2265-2269.
PubMed  |  Direct Link  |  

Vincent, J.L., J. Rello, J. Marshall, E. Silva and A. Anzueto et al., 2009. International study of the prevalence and outcomes of infection in intensive care units. J. Am. Med. Assoc., 302: 2323-2329.
CrossRef  |  Direct Link  |  

https://aac.asm.org/content/40/3/616.short 2001. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbial., 39: 1865-1870.
CrossRef  |  PubMed  |  Direct Link  |